GSK · 10000+ people · Public
Vice President - Oncology Clinical Development, Disease Area Head- Hematology
- Upper Providence
- Hybrid · 2–3 days in office
- Director · manages people
Leads end-to-end clinical development of hematology oncology assets from first-in-human studies through registrational trials, approval and launch. Sets disease-area strategy, chairs governance forums and advisory boards, and line-manages clinical development leads within a global matrix. Distinct for its portfolio-level enterprise scope and hybrid US/UK/Swiss base.
AI/ML